NCT02904616: PHOTOFLUO

Validation of a Medical Device, a Mobile Spectrofluorimeter, Measuring Skin Autofluorescence in Healthy Volunteers.

Completed NA Last updated 8 August 2018

What this trial tests

NA trial testing mobile spectrofluorimeter in Healthy Volunteers in 32 participants. Completed in 5 February 2015.

Timeline

26 January 2015

Primary endpoint
5 February 2015

5 February 2015

Quick facts

Lead sponsor	Institut de Cancérologie de Lorraine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	32
Start date	26 January 2015
Primary completion	5 February 2015
Estimated completion	5 February 2015
Sites	1 location across France

Drugs / interventions tested

• mobile spectrofluorimeter

Conditions studied

• Healthy Volunteers — all drugs for Healthy Volunteers →

Sponsor

Institut de Cancérologie de Lorraine — full company profile →

Who can join

18 and older, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Institut has developed a spectrofluorimeter for the registration and monitoring of skin autofluorescence.

This Spectrofluorometer must be initially validated in healthy volunteers. In the long term, it will be used clinically to measure residual photosensitivity of patients who received a photosensitizer in photodynamic therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.